Participation of industry experts in the elaboration of monographs and chapters of the European Pharmacopoeia.

Eur J Pharm Sci

European Pharmacopoeia Department, EDQM, Council of Europe, F-67081 Strasbourg, France.

Published: October 2016

The European Pharmacopoeia represents an important element in the European regulatory system for medicines. It is elaborated in a co-operation of experts from authorities, academia and industry, assisted by scientific staff from the European Directorate for the Quality of Medicines & HealthCare (EDQM). This article describes the principles of its elaboration with particular focus on the involvement of industry experts.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2016.01.030DOI Listing

Publication Analysis

Top Keywords

industry experts
8
european pharmacopoeia
8
participation industry
4
experts elaboration
4
elaboration monographs
4
monographs chapters
4
european
4
chapters european
4
pharmacopoeia european
4
pharmacopoeia represents
4

Similar Publications

The comprehensive benefit evaluation of LID based on multi-criteria decision-making methods faces technical issues such as the uncertainties and vagueness in hybrid information sources, which can affect the overall evaluation results and ranking of alternatives. This study introduces a multi-indicator fuzzy comprehensive benefit evaluation approach for the selection of LID measures, aiming to provide a robust and holistic framework for evaluating their benefits at the community level. The proposed methodology integrates quantitative environmental and economic indicators with qualitative social benefit indicators, combining the use of the Storm Water Management Model (SWMM) and ArcGIS for scenario-based analysis, and the use of hesitant fuzzy language sets and Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) for decision-making.

View Article and Find Full Text PDF

The purpose of this study is to evaluate the readiness of European inland transport companies for the European Green Deal by analyzing the causal relationships between key factors essential for EGD implementation. The research identifies six critical factors: Investment in Green Technologies, Policy Alignment and Compliance, Stakeholder Collaboration, Resource Management, Employee Training and Engagement, and Emission Reduction Initiatives. This research offers the first integrated evaluation of EGD readiness utilizing a combination of fuzzy-DEMATEL, multiple regression analysis, and Structural Equation Modeling aimed at uncovering systemic interactions among the factors in the system.

View Article and Find Full Text PDF

Large-scale and long-term wildlife research and monitoring using camera traps: a continental synthesis.

Biol Rev Camb Philos Soc

January 2025

Wildlife Observatory of Australia (WildObs), Queensland Cyber Infrastructure Foundation (QCIF), Brisbane, Queensland, 4072, Australia.

Camera traps are widely used in wildlife research and monitoring, so it is imperative to understand their strengths, limitations, and potential for increasing impact. We investigated a decade of use of wildlife cameras (2012-2022) with a case study on Australian terrestrial vertebrates using a multifaceted approach. We (i) synthesised information from a literature review; (ii) conducted an online questionnaire of 132 professionals; (iii) hosted an in-person workshop of 28 leading experts representing academia, non-governmental organisations (NGOs), and government; and (iv) mapped camera trap usage based on all sources.

View Article and Find Full Text PDF

Centrifugal compressors are widely used in the oil and natural gas industry for gas compression, reinjection, and transportation. Fault diagnosis and identification of centrifugal compressors are crucial. To promptly monitor abnormal changes in compressor data and trace the causes leading to these data anomalies, this paper proposes a security monitoring and root cause tracing method for compressor data anomalies.

View Article and Find Full Text PDF

Introduction: Despite research supporting menopause hormonal therapy for menopausal women, its use continues to decline in most European countries and the United States. Experts highlighted the need for global assessment tools to assist clinicians in evaluating treatment for symptomatic menopausal women, which led to the development of the Menopause Treatment Tool, with separate versions for women and healthcare professionals. Both versions of the tool focus on menopausal symptoms, risk levels and suggested actions; the women's tool is administered prior to the consultation, while the clinician tool is administered by the clinician during the clinical consultation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!